Journey Medical Statistics
Total Valuation
Journey Medical has a market cap or net worth of $239.68 million. The enterprise value is $244.67 million.
Important Dates
The next confirmed earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Journey Medical has 26.31 million shares outstanding. The number of shares has increased by 14.33% in one year.
| Current Share Class | 20.31M |
| Shares Outstanding | 26.31M |
| Shares Change (YoY) | +14.33% |
| Shares Change (QoQ) | +3.01% |
| Owned by Insiders (%) | 11.88% |
| Owned by Institutions (%) | 26.12% |
| Float | 13.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 607.33 |
| PS Ratio | 3.55 |
| Forward PS | 5.69 |
| PB Ratio | 11.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.31.
| Current Ratio | 1.27 |
| Quick Ratio | 0.89 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.01 |
Financial Efficiency
Return on equity (ROE) is -57.22% and return on invested capital (ROIC) is -10.91%.
| Return on Equity (ROE) | -57.22% |
| Return on Assets (ROA) | -5.86% |
| Return on Invested Capital (ROIC) | -10.91% |
| Return on Capital Employed (ROCE) | -16.86% |
| Revenue Per Employee | $1.38M |
| Profits Per Employee | -$213,122 |
| Employee Count | 41 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.68 |
Taxes
In the past 12 months, Journey Medical has paid $121,000 in taxes.
| Income Tax | 121,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.46% in the last 52 weeks. The beta is 0.81, so Journey Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +67.46% |
| 50-Day Moving Average | 7.50 |
| 200-Day Moving Average | 6.75 |
| Relative Strength Index (RSI) | 70.59 |
| Average Volume (20 Days) | 196,099 |
Short Selling Information
The latest short interest is 1.77 million, so 6.72% of the outstanding shares have been sold short.
| Short Interest | 1.77M |
| Short Previous Month | 1.58M |
| Short % of Shares Out | 6.72% |
| Short % of Float | 12.79% |
| Short Ratio (days to cover) | 15.74 |
Income Statement
In the last 12 months, Journey Medical had revenue of $56.40 million and -$8.74 million in losses. Loss per share was -$0.40.
| Revenue | 56.40M |
| Gross Profit | 37.52M |
| Operating Income | -6.86M |
| Pretax Income | -8.62M |
| Net Income | -8.74M |
| EBITDA | -2.94M |
| EBIT | -6.86M |
| Loss Per Share | -$0.40 |
Full Income StatementBalance Sheet
The company has $20.29 million in cash and $25.28 million in debt, giving a net cash position of -$4.98 million or -$0.19 per share.
| Cash & Cash Equivalents | 20.29M |
| Total Debt | 25.28M |
| Net Cash | -4.98M |
| Net Cash Per Share | -$0.19 |
| Equity (Book Value) | 19.25M |
| Book Value Per Share | 0.82 |
| Working Capital | 10.79M |
Full Balance SheetCash Flow
| Operating Cash Flow | -2.71M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.71M |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
Gross margin is 66.52%, with operating and profit margins of -12.16% and -15.49%.
| Gross Margin | 66.52% |
| Operating Margin | -12.16% |
| Pretax Margin | -15.28% |
| Profit Margin | -15.49% |
| EBITDA Margin | -5.21% |
| EBIT Margin | -12.16% |
| FCF Margin | n/a |
Dividends & Yields
Journey Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.33% |
| Shareholder Yield | -14.33% |
| Earnings Yield | -3.65% |
| FCF Yield | -1.13% |
Analyst Forecast
The average price target for Journey Medical is $12.67, which is 39.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.67 |
| Price Target Difference | 39.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Journey Medical has an Altman Z-Score of 0.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.11 |
| Piotroski F-Score | 1 |
